Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 1997

View Archived Issues

La Jolla Cancer Res. Found. discloses integrin-binding peptides

Merck & Co. prepares improved inhibitors of protein farnesyltransferase

GABArho receptor antagonists described by University of California

Specific neuronal nicotinic cholinergic channel modulators from Abbott

Pliva prepares new macrolide antibiotics

Yamanouchi discloses new Na+/H+ exchange inhibitors

Compounds for urinary incontinence from Kyowa Hakko

Suntory prepares compounds for thrombocytopenia

Potent and selective beta3-adrenoceptor agonists claimed by Tokyo Tanabe

New vial size of generic leucovorin approved by FDA

Zonagen reports results of second phase III trial of Vasomax

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

New asthma treatment now available in Canada

Proischemic effect of enalapril in MI

Neuroprotective effects of ZD-9379 in rat model

Cypros technology for prevention of organ transplant rejection covered under U.S. patent

Interferon/ribavirin compared to interferon and ribavirin monotherapy in chronic hepatitis C

Centocor's tumor marker assay now available for use in the U.S.

FDA advisory on AIDS drugs

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

Preliminary phase III results with CellPro stem cell concentration product

Promising phase III data presented for Thyrogen in management of thyroid cancer patients

NIH-supported study evaluates efficacy and safety of acellular pertussis vaccine in adults

AWARE Rapid HIV Test equivalent to ELISA and Western blot tests

Apotex forms alliance for generic products in France

Tularik granted U.S. patent covering screens for nucleic acid polymerase inhibitors

VIMRx and Baxter to form new cell therapy company

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...